VICTORIA, BRITISH COLUMBIA--(CCNMatthews - May 5, 2005) -CardioComm Solutions Inc. (TSX VENTURE:CCG) (the "Company","CardioComm"), is pleased to announce that it has signed a U.S.distribution agreement with Lumedx Corporation ("LUMEDX").
The agreement enables LUMEDX to add CardioComm's GEMS(TM)Arrhythmia, Pacing and ICD software, as well as its newly showcasedGlobalCardio(TM) as a complement to its main product line. LUMEDX hasa strong direct sales presence across the U.S., as well as asuccessful inside sales force, all of which is expected to addsignificantly to CardioComm's U.S. sales.
Both companies recognize the benefits of their collaboration, ashistorically LUMEDX and CardioComm have already cooperated on thedevelopment of an HL7 interface between their products, thus enablingbi-directional exchange of information between the systems.
Founded in 1990, LUMEDX is the market leader in developing end-to-end cardiovascular information system solutions. Providing consultingservices, training, and the CardioStar software suite, LUMEDXdelivers complete clinical and business solutions for heart centers.
Stephen R. Martin, President & CEO of CardioComm remarked, "Thisagreement is a great stride forward in our drive to market ourproduct to major cardiac standards, LUMEDX has over 300 customersacross the U.S. that are now potential clients for our products. Ourtwo companies will continue to enjoy the expansion of this workingrelationship."
According to Allyn McAuley, CEO of LUMEDX Corporation, "TheCardioComm relationship will assist us in providing our customerswith a comprehensive solution in the cardiac rhythm managementenvironment. Our goal is total workflow management, includingscheduling, billing capture, inventory control, automated physicianreporting, image review, and outcomes analysis. The GEMS(TM) systemwill allow us to incorporate detailed long term care information onrhythm management patients."
About Lumedx Corporation:
During the past 15 years, Lumedx has assisted more than 300 heartcenters worldwide in building powerful integrated solutions. As theNo. 1 independent cardiovascular systems integrator, LUMEDX'ssoftware, services, and analytics help medical institutions enhancethe quality of patient care, streamline workflow, increase patientvolumes, reduce costs, and grow revenues.
About CardioComm Solutions Inc.:
CardioComm's patented and proprietary technology is used inproducts for the recording, viewing, analyzing and storing ofelectrocardiograms (ECGs), for diagnosis and management of cardiacpatients. The Company's products are sold worldwide through acombination of its external distribution network and its NorthAmerican based sales team. CardioComm has achieved its technicalgoals of improved access and communication through the development ofa real-time ECG viewer. CardioComm is the first company to provide areal-time means of viewing ECGs over a network (LAN, WAN orInternet). This tool enables ECGs to be viewed and controlled live,by physicians, over a global virtual healthcare network. Thistechnology is marketed as Global ECG Management System (GEMS(TM)) andGlobalCardio(TM). CardioComm's software products have been clearedfor sale in the United States by the U.S. Food and DrugAdministration. The Company has earned the latest ISO 13485certification.
On behalf of the Board of Directors of CardioComm Solutions Inc.:
Stephen R. Martin, President & CEO

No comments:
Post a Comment